Hrt Financial LP Gsk PLC Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $841 - $955	20 Added 0.14%	14,763 $642,000
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $593,110 - $703,830	14,743 New	14,743 $642,000
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $2.66 Million - $3.02 Million	-72,721 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $2.49 Million - $2.91 Million	72,721 New	72,721 $2.6 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $213,351 - $231,220	-5,415 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $208,856 - $231,166	5,415 New	5,415 $226,000
Q4 2018 Feb 15, 2019	SELL	$37.8 - $42.69 $220,222 - $248,711	-5,826 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$39.75 - $42.69 $231,583 - $248,711	5,826 New	5,826 $234,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.